Bonafide Health
This is a 6-month, three-arm randomized controlled trial evaluating the efficacy and safety of a dietary supplement drink mix on urinary health outcomes in adult females. Participants will be randomly assigned to one of three study arms and followed for six months to assess changes in urinary health measures.
Urinary tract infections (UTIs) are extremely common, affecting up to 60% of women in their lifetime, with 20-40% experiencing recurrent infections. Recurrent UTIs-defined as two infections in six months or three in one year-create a significant burden on quality of life and healthcare costs. Antibiotics are the standard treatment, but repeated use can contribute to antibiotic resistance, incomplete bacterial clearance, and disruption of the microbiome. Non-antibiotic approaches, such as D-mannose, vitamins, and hydration support, have shown potential to help reduce UTI recurrence. D-mannose…
Inclusion Criteria: 1. Healthy biological females who are 18-75 years of age (inclusive). 2. Have a history of recurrent uncomplicated UTI (≥2 UTIs in the last 6 months and/or ≥3 UTIs in the last 12 months). 3. Are within 7 days of the enrollment trigger event (acute UTI). 4. In good general health (no active or uncontrolled diseases or conditions besides recurrent UTIs) and able to consume the study product. 5. BMI 18.5-39.9 kg/m\^2 6. Have reliable, stable access to Wi-Fi and a smart phone/device. 7. Willing and able to agree to the requirements and restrictions of this study, willing to gi…
2g D-Mannose drink mix
Arctuva estimate
Verify or correct the compensation shown for this listing.